Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01098253 · ClinicalTrials.gov registry record · NA

Integrating Depression Services Into DM Management

A NA study of Depression and Type 2 Diabetes Mellitus, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
182
Enrollment target
1
Study location

NCT01098253 is a NA study of Depression and Type 2 Diabetes Mellitus that has completed, run by University of Pennsylvania. The registered enrollment target is 182 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01098253, a NA study of Depression and Type 2 Diabetes Mellitus, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
182 participants
Enrollment target
1
Study location

Study Summary

The goal of this proposal is to integrate depression services into improving adherence for oral hypoglycemic agents so that a single program can assist patients. The investigators hypothesized that patients in the intervention would demonstrate improved adherence to patients' oral hypoglycemic agents and antidepressants as well as improved clinical outcomes.

Interventions

  • BEHAVIORAL Adherence Intervention

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2009-01
Est. Completion 2011-04
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01098253

The ClinicalTrials.gov registry entry for NCT01098253 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (77% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Adherence Intervention is the first listed.

NCT01098253 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01098253 about?

NCT01098253 is a clinical study titled "Integrating Depression Services Into DM Management". The goal of this proposal is to integrate depression services into improving adherence for oral hypoglycemic agents so that a single program can assist patients. The investigators hypothesized that patients in the intervention would demonstrate improved adherence to patients' oral hypoglycemic agent...

What is the current status of trial NCT01098253?

This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2009-01. Estimated completion is 2011-04.

What conditions does trial NCT01098253 study?

This clinical trial studies the following conditions: Depression, Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT01098253?

The interventions under investigation include: Adherence Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01098253?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01098253 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.